362 related articles for article (PubMed ID: 12414951)
1. Toward testing the hypothesis that group B coxsackieviruses (CVB) trigger insulin-dependent diabetes: inoculating nonobese diabetic mice with CVB markedly lowers diabetes incidence.
Tracy S; Drescher KM; Chapman NM; Kim KS; Carson SD; Pirruccello S; Lane PH; Romero JR; Leser JS
J Virol; 2002 Dec; 76(23):12097-111. PubMed ID: 12414951
[TBL] [Abstract][Full Text] [Related]
2. Coxsackievirus B3 infection and type 1 diabetes development in NOD mice: insulitis determines susceptibility of pancreatic islets to virus infection.
Drescher KM; Kono K; Bopegamage S; Carson SD; Tracy S
Virology; 2004 Nov; 329(2):381-94. PubMed ID: 15518817
[TBL] [Abstract][Full Text] [Related]
3. Group B coxsackievirus diabetogenic phenotype correlates with replication efficiency.
Kanno T; Kim K; Kono K; Drescher KM; Chapman NM; Tracy S
J Virol; 2006 Jun; 80(11):5637-43. PubMed ID: 16699045
[TBL] [Abstract][Full Text] [Related]
4. Group B coxsackievirus myocarditis and pancreatitis: connection between viral virulence phenotypes in mice.
Tracy S; Höfling K; Pirruccello S; Lane PH; Reyna SM; Gauntt CJ
J Med Virol; 2000 Sep; 62(1):70-81. PubMed ID: 10935991
[TBL] [Abstract][Full Text] [Related]
5. Coxsackievirus infections and NOD mice: relevant models of protection from, and induction of, type 1 diabetes.
Tracy S; Drescher KM
Ann N Y Acad Sci; 2007 Apr; 1103():143-51. PubMed ID: 17376828
[TBL] [Abstract][Full Text] [Related]
6. Characterization of an infectious cDNA copy of the genome of a naturally occurring, avirulent coxsackievirus B3 clinical isolate.
Lee CK; Kono K; Haas E; Kim KS; Drescher KM; Chapman NM; Tracy S
J Gen Virol; 2005 Jan; 86(Pt 1):197-210. PubMed ID: 15604447
[TBL] [Abstract][Full Text] [Related]
7. Secondary heterotypic versus homotypic infection by Coxsackie B group viruses: impact on early and late histopathological lesions and virus genome prominence.
Yu JZ; Wilson JE; Wood SM; Kandolf R; Klingel K; Yang D; McManus BM
Cardiovasc Pathol; 1999; 8(2):93-102. PubMed ID: 10724506
[TBL] [Abstract][Full Text] [Related]
8. The CVB and etiology of type 1 diabetes.
Drescher KM; Tracy SM
Curr Top Microbiol Immunol; 2008; 323():259-74. PubMed ID: 18357774
[TBL] [Abstract][Full Text] [Related]
9. Coxsackievirus can persist in murine pancreas by deletion of 5' terminal genomic sequences.
Tracy S; Smithee S; Alhazmi A; Chapman N
J Med Virol; 2015 Feb; 87(2):240-7. PubMed ID: 25111164
[TBL] [Abstract][Full Text] [Related]
10. Strains of coxsackie virus B4 differed in their ability to induce acute pancreatitis and the responses were negatively correlated to glucose tolerance.
Hindersson M; Orn A; Harris RA; Frisk G
Arch Virol; 2004 Oct; 149(10):1985-2000. PubMed ID: 15669109
[TBL] [Abstract][Full Text] [Related]
11. Platelets interact with Coxsackieviruses B and have a critical role in the pathogenesis of virus-induced myocarditis.
Negrotto S; Jaquenod de Giusti C; Rivadeneyra L; Ure AE; Mena HA; Schattner M; Gomez RM
J Thromb Haemost; 2015 Feb; 13(2):271-82. PubMed ID: 25393316
[TBL] [Abstract][Full Text] [Related]
12. Expression of an antigenic adenovirus epitope in a group B coxsackievirus.
Höfling K; Tracy S; Chapman N; Kim KS; Smith Leser J
J Virol; 2000 May; 74(10):4570-8. PubMed ID: 10775593
[TBL] [Abstract][Full Text] [Related]
13. [Coxsackievirus B infection and pathogenesis of type 1 diabetes].
Nekoua MP; Mercier A; Vergez I; Morvan C; Mbani CJ; Sane F; Lobert D; Engelmann I; Romond MB; Alidjinou EK; Hober D
Virologie (Montrouge); 2022 DéCembre 01; 26(6):415-430. PubMed ID: 36565260
[TBL] [Abstract][Full Text] [Related]
14. A Coxsackievirus B vaccine protects against virus-induced diabetes in an experimental mouse model of type 1 diabetes.
Stone VM; Hankaniemi MM; Svedin E; Sioofy-Khojine A; Oikarinen S; Hyöty H; Laitinen OH; Hytönen VP; Flodström-Tullberg M
Diabetologia; 2018 Feb; 61(2):476-481. PubMed ID: 29151123
[TBL] [Abstract][Full Text] [Related]
15. Group B coxsackieviruses and autoimmunity: focus on Type 1 diabetes.
Sané F; Moumna I; Hober D
Expert Rev Clin Immunol; 2011 May; 7(3):357-66. PubMed ID: 21595602
[TBL] [Abstract][Full Text] [Related]
16. Replication Activities of Major 5' Terminally Deleted Group-B Coxsackievirus RNA Forms Decrease PCSK2 mRNA Expression Impairing Insulin Maturation in Pancreatic Beta Cells.
Callon D; Guedra A; Lebreil AL; Heng L; Bouland N; Fornès P; Berri F; Andreoletti L
Viruses; 2022 Dec; 14(12):. PubMed ID: 36560784
[TBL] [Abstract][Full Text] [Related]
17. Persistent infection of human pancreatic islets by coxsackievirus B is associated with alpha interferon synthesis in beta cells.
Chehadeh W; Kerr-Conte J; Pattou F; Alm G; Lefebvre J; Wattré P; Hober D
J Virol; 2000 Nov; 74(21):10153-64. PubMed ID: 11024144
[TBL] [Abstract][Full Text] [Related]
18. Development of a new mouse model for coxsackievirus-induced myocarditis by attenuating coxsackievirus B3 virulence in the pancreas.
Pinkert S; Pryshliak M; Pappritz K; Knoch K; Hazini A; Dieringer B; Schaar K; Dong F; Hinze L; Lin J; Lassner D; Klopfleisch R; Solimena M; Tschöpe C; Kaya Z; El-Shafeey M; Beling A; Kurreck J; Van Linthout S; Klingel K; Fechner H
Cardiovasc Res; 2020 Aug; 116(10):1756-1766. PubMed ID: 31598635
[TBL] [Abstract][Full Text] [Related]
19. Viral infection of engrafted human islets leads to diabetes.
Gallagher GR; Brehm MA; Finberg RW; Barton BA; Shultz LD; Greiner DL; Bortell R; Wang JP
Diabetes; 2015 Apr; 64(4):1358-69. PubMed ID: 25392246
[TBL] [Abstract][Full Text] [Related]
20. Prophylactic oral administration of metabolically active insulin entrapped in isobutylcyanoacrylate nanocapsules reduces the incidence of diabetes in nonobese diabetic mice.
Saï P; Damagé C; Rivereau AS; Hoeltzel A; Gouin E
J Autoimmun; 1996 Dec; 9(6):713-22. PubMed ID: 9115573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
